Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice

The nucleotide second messenger 3', 5'-cyclic adenosine monophosphate (cAMP) and 3', 5'-cyclic guanosine monophosphate (cGMP) mediate fundamental functions of the brain, including learning and memory. Phosphodiesterase 3 (PDE3) can hydrolyze both cAMP and cGMP and appears to be i...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuichi Yanai (Author), Tetsuro Tago (Author), Jun Toyohara (Author), Tomoko Arasaki (Author), Shogo Endo (Author)
Format: Book
Published: Frontiers Media S.A., 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_20f33d326e9e4dfeb97f1159b8c13c05
042 |a dc 
100 1 0 |a Shuichi Yanai  |e author 
700 1 0 |a Tetsuro Tago  |e author 
700 1 0 |a Jun Toyohara  |e author 
700 1 0 |a Tomoko Arasaki  |e author 
700 1 0 |a Shogo Endo  |e author 
245 0 0 |a Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice 
260 |b Frontiers Media S.A.,   |c 2022-12-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2022.1031637 
520 |a The nucleotide second messenger 3', 5'-cyclic adenosine monophosphate (cAMP) and 3', 5'-cyclic guanosine monophosphate (cGMP) mediate fundamental functions of the brain, including learning and memory. Phosphodiesterase 3 (PDE3) can hydrolyze both cAMP and cGMP and appears to be involved in the regulation of their contents in cells. We previously demonstrated that long-term administration of cilostazol, a PDE3 inhibitor, maintained good memory performance in aging mice. Here, we report on studies aimed at determining whether cilostazol also reverses already-impaired memory in aged male mice. One month of oral 1.5% cilostazol administration in 22-month-old mice reversed age-related declines in hippocampus-dependent memory tasks, including the object recognition and the Morris water maze. Furthermore, cilostazol reduced neuroinflammation, as evidenced by immunohistochemical staining, and increased glucose uptake in the brain, as evidence by positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-d-glucose ([18F]FDG). These results suggest that already-expressed memory impairment in aged male mice that depend on cyclic nucleotide signaling can be reversed by inhibition of PDE3. The reversal of age-related memory impairments may occur in the central nervous system, either through cilostazol-enhanced recall or strengthening of weak memories that otherwise may be resistant to recall. 
546 |a EN 
690 |a phosphodiesterase 3 inhibitor 
690 |a cilostazol 
690 |a memory 
690 |a neuroinflammation 
690 |a [18F]FDG PET 
690 |a aging 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 13 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2022.1031637/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/20f33d326e9e4dfeb97f1159b8c13c05  |z Connect to this object online.